Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 24, 2013, Pages

  Cywes Bentley, Colette ^a   Skurnik, David ^a   Zaidi, Tanweer ^a   Roux, Damien ^a   DeOliveira, Rosane B ^b   Garrett, Wendy S ^c   Lu, Xi ^a   O'Malley, Jennifer ^a   Kinzel, Kathryn ^a   Zaidi, Tauqeer ^a   Rey, Astrid ^d   Perrin, Christophe ^d   Fichorova, Raina N ^a   Kayatani, Alexander K K ^e   Maira Litràn, Tomas ^a   Gening, Marina L ^f   Tsvetkov, Yury E ^f   Nifantiev, Nikolay E ^f   Bakaletz, Lauren O ^g   Pelton, Stephen I ^h   Golenbock, Douglas T ^b   Pier, Gerald B ^a   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d SANOFI   (France)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f N D ZELINSKY INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^g THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Animal models; Carbohydrates; Immunotherapy; Infectious diseases; Malaria

Indexed keywords

GLUCOSAMINE; IMMUNOGLOBULIN G ANTIBODY; POLY N ACETYL DEXTRO GLUCOSAMINE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CELL PROTECTION; COLITIS; EUKARYOTE; GENE LOCUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; IMMUNITY; LISTERIA MONOCYTOGENES; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROKARYOTE; PROTEIN SYNTHESIS; PROTOZOON; SPOROZOITE; STREPTOCOCCUS PYOGENES; TRICHOMONAS VAGINALIS;

ANIMAL MODELS; CARBOHYDRATES; IMMUNOTHERAPY; INFECTIOUS DISEASES; MALARIA;

ACETYLGLUCOSAMINE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL CAPSULES; BACTERIAL INFECTIONS; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; MALARIA; MICE; MICE, INBRED C57BL; MYCOSES; OPSONIN PROTEINS; PLASMODIUM BERGHEI; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TIME FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; EUKARYOTA; HAEMOPHILUS INFLUENZAE; LISTERIA MONOCYTOGENES; MUS; NEGIBACTERIA; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS SEROGROUP B; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; POSIBACTERIA; PROKARYOTA; PROTOZOA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TRICHOMONAS VAGINALIS;

EID: 84879004304     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1303573110     Document Type: Article

References (58)

1. Centers for Disease Control and Prevention (CDC) (1999) Control of infectious diseases. MMWR Morb Mortal Wkly Rep 48(29):621-629.
2. Kwong PD, Mascola JR (2012) Human antibodies that neutralize HIV-1: Identification, structures, and B cell ontogenies. Immunity 37(3):412-425.
3. Lingwood D, et al. (2012) Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489(7417):566-570.
4. Toltzis P, Jacobs MR (2005) The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Infect Dis Clin North Am 19(3):629-645. (Pubitemid 41133533)
5. Ladhani SN (2012) Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom. Clin Ther 34(2):385-399.
6. Tan LK, Carlone GM, Borrow R (2010) Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med 362(16):1511-1520.
7. Engels EA, Lau J (2000) Vaccines for preventing typhoid fever. Cochrane Database Syst Rev 2):CD001261.
8. Mack D, et al. (1996) The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: Purification and structural analysis. J Bacteriol 178(1):175-183. (Pubitemid 26006081)
9. McKenney D, et al. (1999) Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284(5419):1523-1527.
10. Wang X, Preston JF, 3rd, Romeo T (2004) The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 186(9):2724-2734. (Pubitemid 38525927)
11. Parise G, Mishra M, Itoh Y, Romeo T, Deora R (2007) Role of a putative polysaccharide locus in Bordetella bio film development. J Bacteriol 189(3):750-760. (Pubitemid 46183849)
12. Kaplan JB, et al. (2004) Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol 186(24):8213-8220. (Pubitemid 39603210)
13. Skurnik D, et al. (2012) Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis 205(11):1709-1718.
14. Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T (2012) Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun 80(2):651-656.
15. Heilmann C, et al. (1996) Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol 20(5):1083-1091. (Pubitemid 26198280)
16. Lillard JW, Jr., Fetherston JD, Pedersen L, Pendrak ML, Perry RD (1997) Sequence and genetic analysis of the hemin storage (hms) system of Yersinia pestis. Gene 193(1):13-21. (Pubitemid 27303599)
17. Maira-Litrán T, Kropec A, Goldmann DA, Pier GB (2005) Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal poly-N-acetyl-β-(1-6)- glucosamine. Infect Immun 73(10):6752-6762. (Pubitemid 41368842)
18. Izano EA, et al. (2007) Poly-N-acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniae. Microb Pathog 43(1):1-9. (Pubitemid 46678642)
19. Skurnik D, et al. (2010) Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest 120(9):3220-3233.
20. Skurnik D, et al. (2012) Natural antibodies in normal human sera inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clin Infect Dis 205:1709-1718.
21. Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB (2006) Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun 74(5):2742-2750. (Pubitemid 43672983)
22. Gening ML, et al. (2010) Synthetic β-(1→6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 78(2):764-772.
23. Cerca N, et al. (2007) Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)-glucosamine. Infect Immun 75(7):3406-3413. (Pubitemid 47040941)
24. Choi AHK, Slamti L, Avci FY, Pier GB, Maira-Litrán T (2009) The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 191(19):5953-5963.
25. Yoong P, Cywes-Bentley C, Pier GB (2012) Poly-N-acetylglucosamine expression by wild-type Yersinia pestis is maximal at mammalian, not flea, temperatures. MBio 3: e00217-00212, 10.01128/mBio.00217-00212.
26. Maira-Litrán T, et al. (2002) Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun 70(8):4433-4440. (Pubitemid 34790954)
27. Cerca N, et al. (2007) Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci USA 104(18):7528-7533. (Pubitemid 47185940)
28. Pozzi C, et al. (2012) Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens. PLoS ONE 7(10):e46648.
29. Manuel SG, et al. (2007) Role of active-site residues of dispersin B, a biofilm-releasing beta-hexosaminidase from a periodontal pathogen, in substrate hydrolysis. FEBS J 274(22):5987-5999. (Pubitemid 350045809)
30. Fazekas E, Kandra L, Gyémánt G (2012) Model for β-1,6-N-acetylglucosamine oligomer hydrolysis catalysed by DispersinB, a biofilm degrading enzyme. Carbohydr Res 363:7-13.
31. Ramasubbu N, Thomas LM, Ragunath C, Kaplan JB (2005) Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol 349(3):475-486. (Pubitemid 40724559)
32. Pier GB, et al. (2004) Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J Immunol 173(9):5671-5678. (Pubitemid 39392155)
33. Ryan CM, Mehlert A, Richardson JM, Ferguson MA, Johnson PJ (2011) Chemical structure of Trichomonas vaginalis surface lipoglycan: A role for short galactose (β1-4/3) N-acetylglucosamine repeats in host cell interaction. J Biol Chem 286(47):40494-40508〉.
34. Tan TQ (2012) Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 25(3):409-419.
35. Pham TH, et al. (2012) Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infect Immun 80(6):2133-2140.
36. Granoff DM (2009) Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine 27(Suppl 2):B117-B125.
37. Vlock D, Lee JC, Kropec-Huebner A, Pier GB (2010) Pre-clinical and initial phase I evaluations of a fully human monoclonal antibody directed against the PNAG surface polysaccharide on Staphylococcus aureus. Abstracts of the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy 2010 (Am Soc Microbiology, Washington, DC), G1-1654/329 (abstr).
38. Thigpen MC, et al.; Emerging Infections Programs Network (2011) Bacterial meningitis in the United States, 1998-2007. N Engl J Med 364(21):2016-2025.
39. Kenny JJ, Guelde G, Fischer RT, Longo DL (1994) Induction of phosphocholine-specific antibodies in X-linked immune deficient mice: in vivo protection against a Streptococcus pneumoniae challenge. Int Immunol 6(4):561-568. (Pubitemid 24111607)
40. Rouphael NG, Stephens DS (2012) Neisseria meningitidis: Biology, microbiology, and epidemiology. Methods Mol Biol 799:1-20.
41. Garrett WS, et al. (2007) Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131(1):33-45. (Pubitemid 47505255)
42. Garrett WS, et al. (2010) Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8(3):292-300.
43. Franke-Fayard B, et al. (2004) A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol 137(1):23-33. (Pubitemid 38987939)
44. Jeon B, Muraoka W, Scupham A, Zhang Q (2009) Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial resistance and natural transformation of Campylobacter jejuni. J Antimicrob Chemother 63(3):462-468.
45. Trzciński K, Thompson CM, Lipsitch M (2004) Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J Bacteriol 186(11):3447-3452. (Pubitemid 38661541)
46. Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357-372.
47. Epstein AK, Pokroy B, Seminara A, Aizenberg J (2011) Bacterial biofilm shows persistent resistance to liquid wetting and gas penetration. Proc Natl Acad Sci USA 108(3):995-1000.
48. Perry RD, et al. (2004) Temperature regulation of the hemin storage (Hms+) phenotype of Yersinia pestis is posttranscriptional. J Bacteriol 186(6):1638-1647. (Pubitemid 38314509)
49. Sloan GP, Love CF, Sukumar N, Mishra M, Deora R (2007) The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract. J Bacteriol 189(22):8270-8276. (Pubitemid 350178939)
50. Matthysse AG, Deora R, Mishra M, Torres AG (2008) Polysaccharides cellulose, poly-beta-1,6-N-acetyl-D-glucosamine, and colanic acid are required for optimal binding of Escherichia coli O157:H7 strains to alfalfa sprouts and K-12 strains to plastic but not for binding to epithelial cells. Appl Environ Microbiol 74(8):2384-2390. (Pubitemid 351555449)
51. Kallmeyer J, Pockalny R, Adhikari RR, Smith DC, D'Hondt S (2012) Global distribution of microbial abundance and biomass in subseafloor sediment. Proc Natl Acad Sci USA 109(40):16213-16216.
52. Gerke C, Kraft A, Süssmuth R, Schweitzer O, Götz F (1998) Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem 273(29):18586-18593. (Pubitemid 28334789)
53. Itoh Y, et al. (2008) Roles of pgaABCD genes in synthesis, modification, and export of the Escherichia coli biofilm adhesin poly-beta-1,6-N-acetyl-D- glucosamine. J Bacteriol 190(10):3670-3680.
54. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB (2007) Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 86(7):618-622.
55. Romero-Steiner S, et al. (2006) Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol 13(2):165-169. (Pubitemid 43383782)
56. Preston MJ, et al. (1995) Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun 63(9):3497-3501.
57. Lackner P, et al. (2006) Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol 32(2):177-188.
58. van Vianen PH, et al. (1993) Flow cytometric screening of blood samples for malaria parasites. Cytometry 14(3):276-280.